As Europharm Swedish member has a product under development as treatment for plaque psoriasis.
They have been granted an EU patent for the formulation.
- The product benefits are:
- Unique formulation with a concentration of 0.025% solution, instead of 0.05%
- Pleasant odor
- Alcohol free
- Easy dosing
- Clear and stable solution
- Spray gives easy application and well absorbed
- Shelf life of three years
- Aclozol is an original and exclusive concept based on a unique combination of ingredients
- Available in a 300 ml plastic bottle with a tamper proof cap
- Represents a complete management of signs and symptoms of severe Psoriasis.
They also have a basic file, to be supplemented including with a clinical study.
As this project does not fit into their areas of interest, they are
Interested in finding a suitable firm to take over the project.